CYP cynata therapeutics limited

The Phase I/IIb Nereid Study Is Now Registered, page-3

  1. 2,282 Posts.
    lightbulb Created with Sketch. 1205
    MCA -maybe mesenchymal cells from autologous sources - so specifically ipscs where the four factors involved in doing the induction of pluripotency are applied to an autologous source and what is then done is that the ipscs are directed towards a mesenchymal fate --- is that what is going on there ?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
18.0¢
Change
0.015(9.09%)
Mkt cap ! $40.67M
Open High Low Value Volume
17.5¢ 18.0¢ 17.5¢ $29.91K 170.2K

Buyers (Bids)

No. Vol. Price($)
2 35924 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 27622 2
View Market Depth
Last trade - 15.57pm 28/07/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.